Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma V Petley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The FEBS Journal|March 24, 2018
Tumor-derived exosomes modulate T cell function through transfer of RNAImran G House, Emma V Petley, Paul A Beavis
Immunology and Cell Biology|May 23, 2017
A novel combination strategy for effectively targeting cancer stem-like cellsPaul A Beavis, Emma V Petley, Phillip K Darcy
Chemmedchem|May 14, 2020
The Synthesis and Anti-tumour Properties of Poly Ethoxy Ethyl Glycinamide (PEE-G) Scaffolds with Multiple PD-1 Peptides AttachedRinu Shrestha, Emma V Petley, Kathryn J Farrand, et al.
Scientific Reports|March 9, 2022
Differential location of NKT and MAIT cells within lymphoid tissueDarryl N Johnson, Zheng Ruan, Emma V Petley, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The FEBS Journal|March 24, 2018
Tumor-derived exosomes modulate T cell function through transfer of RNAImran G House, Emma V Petley, Paul A Beavis
Immunology and Cell Biology|May 23, 2017
A novel combination strategy for effectively targeting cancer stem-like cellsPaul A Beavis, Emma V Petley, Phillip K Darcy
Chemmedchem|May 14, 2020
The Synthesis and Anti-tumour Properties of Poly Ethoxy Ethyl Glycinamide (PEE-G) Scaffolds with Multiple PD-1 Peptides AttachedRinu Shrestha, Emma V Petley, Kathryn J Farrand, et al.
Scientific Reports|March 9, 2022
Differential location of NKT and MAIT cells within lymphoid tissueDarryl N Johnson, Zheng Ruan, Emma V Petley, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Pageof 2